
Peter Warnke, MD
Peter Warnke, MD
Professor of Neurological Surgery
Professor of Neurology
Professor of Pediatrics
Director, Stereotactic and Functional Neurosurgery
Specialties
- Neurosurgery
- Neuro-Oncology (Brain & Spinal Tumors)
- Pediatric Neurosurgery
- More
Locations
- Chicago - Hyde Park
- Chicago - River East
- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
Internationally renowned neurosurgeon Peter Warnke, MD, has performed more than 7,000 stereotactic surgeries and more than 3,000 brain tumor surgeries. Dr. Warnke provides neurosurgical care for the treatment of:
- Movement disorders (including Parkinson's disease, dystonia, torticollis, and tics), with particular expertise in pediatric dystonia, choreoathetosis, and cerebral palsy
- Epilepsy
- Pediatric epilepsy
- Primary and secondary brain tumors, including chiasmal/hypothalamic gliomas and craniopharyngiomas
- Pediatric brain tumors
He routinely performs neurosurgical procedures with proven expertise, including:
- Brain tumor surgery
- Epilepsy surgery
- Pediatric epilepsy surgery
- Deep brain stimulation (DBS)
- Endoscopic neurosurgery
- Stereotactic radiosurgery
- Motor cortex stimulation
- Radiofrequency lesioning
- Laser ablation
Dr. Warnke is one of the few neurosurgeons fellowship-trained in pediatric neurosurgery, brain tumor surgery (neurooncology), and movement and epilepsy surgery. He has treated one of the largest series of low grade gliomas in adults and children (more than 1,000) and intrinsic other brain tumors.
In 2021, Dr. Warnke became the first neurosurgeon in Illinois — and only second worldwide — to perform laser hemispherectomy for the treatment of drug-resistant epilepsy in a child. This highly innovative surgical technique carries significantly lower risk of complications compared to the traditional open hemispherectomy procedure (Operative Neurosurgery, 2023).
Dr. Warnke directs the pediatric and adult epilepsy surgery program within the Comprehensive Epilepsy Center and the MRI-Guided Laser Ablation Program for epilepsy and tumors, with more than 400 laser surgeries performed at UChicago Medicine already.
Dr. Warnke has a large epilepsy surgery practice and performs open resections, laser ablations and neurostimulation for epilepsy in children and adults. This entails routinely robotic implantations of Stereo-EEG electrodes with image guidance and an intraoperative CT.
He directs the SLATE , NAUTILUS and RESPONSE trial in epilepsy surgery, investigating laser ablation and closed loop brain stimulation as a new minimally invasive alternative to open surgery. Also, new biological treatments for epilepsy are explored using cell transplants to silence epileptic areas (Neurona Trial).
In addition, Dr. Warnke has a large deep brain stimulation practice for Parkinson’s, essential tremor and dystonia, and was the first neurosurgeon in Chicago to use directional deep brain stimulation.
Dr. Warnke performs psychiatric neurosurgery, in collaboration with the ACID research group in the Department of Psychiatry, predominantly for obsessive compulsive disorder. He has the largest series of anterior capsulotomies performed by an interstitial laser technique (Journal of Neurology, Neurosurgery and Psychiatry, 2022)
He has special expertise in stereotactic radiosurgery, including interstitial radiosurgery and stereotactically guided endoscopy which has been combined with image guidance and stereotactic targeting to reduce side effects and increase precision (World Neurosurgery 2020). He also provides care for patients with pain syndromes, including trigeminal neuralgia and neuropathic pain.
He researches the development of biological and minimally invasive treatments for epilepsy, movement disorders and brain tumors using functional imaging and fiber tracking to target deep seated, complex tumors.
Dr. Warnke’s research focuses on Brain-Computer Interface for the motor and sensory cortex and mechanisms of memory formation and is funded collaboratively by 4 NIH grants including the Brain Initiative (Proc Natl. Acad Sci, 2022).
He studies the effect of laser energy on tumor permeability, blood flow and extracellular space in brain tumors and the effect of nuclear export proteins and their inhibition on recurrent malignant gliomas.
Dr. Warnke is the associate editor of the Journal of Neurology, Neurosurgery and Psychiatry, which has the highest impact factor among neurosurgical journals (Impact Factor 13.65).
Areas of Expertise
- Brain Tumors
- Hydrocephalus
- Epilepsy
- Movement Disorders
- Stereotactic Radiosurgery
- Trigeminal Neuralgia
- Pediatric Movement Disorders
- Deep Brain Stimulation (DBS)
- Pediatric Epilepsy
- Pediatric Brain & Spinal Cord Tumors
- Endoscopic Neurosurgery
- Epilepsy Surgery
- Laser Ablation
Practicing Since
- 1991
Languages Spoken
- English
- French
- German
- Italian
Medical Education
- University of Freiburg
Internship
- Nordstadt Hospital
Residency
- Saarland University Hospital; University of Freiburg Hospital
Fellowship
- Evanston Hospital
Memberships & Medical Societies
- American Epilepsy Society
- European Society for Stereotactic and Functional Neurosurgery
- World Society for Stereotactic and Functional Neurosurgery
- International Stereotactic Radiosurgery Society
- American Association of Neurological Surgeons
- Congress of Neurological Surgeons
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If you have questions regarding your insurance benefits at UChicago Medicine, please contact our financial counseling team at OPSFinancialCounseling@uchospitals.edu.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.
Ratings & Reviews (25)
4.6/5 357 RatingsMovement Disorders, Parkinson's, Deep Brain Stimulation: Expert Q&A
Our experts at UChicago Medicine offer deep brain stimulation to treat patients who have movement disorders. DBS involves placing small electrodes into the brain. Dr. Tao Xie and neurosurgeon Dr. Peter Warnke join us to discuss the diagnosis and management of Parkinson's disease and DBS as a treatment option.
